– Interventional Radiologist, Tumor Ablation USA
Future trends such as immunotherapy used in combination with ablation technologies is gaining prominence. Acceptance of tumor ablation to treat cancer types such as breast cancer is expected to increase as clinical evidence suggests good patient outcomes.
Competitor landscape covers market events such as emerging companies, product approvals, clinical trials, partnerships etc. Competitor activities such announcement of new clinical data from NAVBLATE study on biomicroscopically used microwave ablation (MWA) for treating malignant lung tumors by Medtronic; showcase of the TULSA-PRO thermal ultrasound-based treatment for patients with prostrate cancer and benign prostrate hyperplasia by Profound Medical are covered in the report